A Chemical Engineer by training, David Sans holds a PhD in Chemometrics and Artificial Intelligence from the labs of Dr. Stoessel at the ETH in Zurich, as well as a Board Certification in Cell Therapies from Mount Sinai Medical Center. David holds FINRA Series 7, 63, 15, and 55 licenses, making him a fully qualified Healthcare Investment Banking professional. David has more than 12 years of experience in Healthcare Investment Banking, where he has provided a full range of investment banking advisory services, including mergers and acquisitions, project finance, capital raising, and special circumstance consulting services. The Healthcare Investment Banking transactions conducted by David's clients have totaled over 100 since 2008. David's clients include financial institutions, health-care institutional investors, and strategic partners. The AI Pathology platform at Mount Sinai Hospital in New York City, which David developed and sold to Philips Corporation in 2021, is one example of David's work. Among David's initial public offerings (IPOs) is Annovis Bio, which is expected to generate $600 million in value from its $10 million IPO in December 2020. As Vice President of Finance and Investment Strategy at ImClone Systems, David reported to the CEO and the Board of Directors, and as Managing Director of Healthcare Banking at ThinkEquity, David gained extensive experience in the healthcare industry. When Glivec® (Imatinib) was first introduced in Switzerland, David worked as a Sr. Medical Scientist at Novartis. Later, he worked as Director of Market Analytics at Pfizer with the introduction of Rebif® (interferon beta-1a for multiple sclerosis) and Macugen.

David Sans pointed out that, There are several applications for stem cells, including orthopedics and sports injuries. While the FDA does not oversee foreign therapies, it does regulate a restricted number of stem cell applications. If a clinic violates the standards, the FDA will send a warning letter and may suspend treatment. In addition, the FDA is expanding inspections and examining stem cells in the same way that it does prescription medications. Please continue reading to discover more about the advantages of stem-cell therapy. This article will go through some of the most prevalent uses.

Human stem cells have been shown in one research to be capable of replacing normal blood arteries. The Massachusetts General Hospital research team successfully transplanted stem cells into experimental mice. The mice developed networks of blood-perfused arteries within two weeks. The created blood arteries were virtually as excellent as the natural ones nearby. The researchers want to apply this method to the treatment of vascular and cardiovascular illnesses. Doctors may employ stem cells in the future to repair lost brain tissue in people suffering from disorders such as Parkinson's disease.

Transplantation is one of the most prevalent use for stem cells. Donor organs are often in short supply and are utilized by a large number of persons in need of transplants. Using stem cells to replace organs might be a long-term solution. Furthermore, cancer research is developing in a variety of domains. The study might lead to better therapy for a number of disorders. Currently, researchers can effectively treat patients with type 1 diabetes utilizing cells from a partly matched donor.

Another usage is in the treatment of Parkinson's disease, which is caused by brain cell destruction. The new therapies may be able to repair damaged brain tissue and regenerate specialized cells. They could even be able to halt uncontrollable muscular movements. Furthermore, scientists have successfully differentiated embryonic stem cells into specialized cells. They seek to create cardiac cells in the lab. The generated heart tissue might be employed to repair damaged cardiac tissues as well as repopulate the heart. In type I diabetes, a patient may be given pancreatic cells to replace insulin-producing cells that have been destroyed by the immune system.

David Sans suggested that, There are still many unknowns and mysteries concerning stem cells. However, multiple clinical studies have already been conducted, and a number of individuals have benefitted from this medication. It has also been employed in medical study and treatment of a variety of ailments. Although there are many uses, additional study is required to decide which of these therapies is best for you. It is also crucial to realize that there are still many misconceptions about stem cells and how they are employed.

Stem cells may be employed in a variety of ways. They are most typically utilized as a kind of treatment for a variety of disorders. Aside from being useful for therapy, stem cells may hold the answer to reducing the biological aging process. A doctor's understanding of stem cell utilization is critical for the treatment of a variety of illnesses. They may potentially be employed in surgical operations in the near future. In the meanwhile, the advantages of stem cells are limitless.

David Sans demonstrated that, In addition to being utilized to treat illness, stem cells may be employed to create disease models in dishes. Despite the fact that the vast majority of individuals with hereditary disorders do not have genetic diseases, stem cells may aid in assessing whether or not medications are beneficial. In addition, unlike other illnesses, stem cells have the potential to prevent the immune system from rejecting an organ transplant. Aside from these, there are several more applications for stem cells. Researchers, for example, may utilize these cells to develop artificial organs.

A research done in Saudi Arabia looked at public awareness and understanding about stem cells. They polled health care practitioners and patients and distributed a questionnaire with 16 items. The poll findings were evaluated and analysed to assess how much information they had about stem cells and if they thought they might treat cancer. Several additional research efforts have focused on the use of stem cells in medical therapy. Females are more interested in stem cell therapy than males, according to Saudi experts, and they are even more aware about the technology's possibilities.